세계의 란셋 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Lancets was estimated to be worth US$ 1673 million in 2024 and is forecast to a readjusted size of US$ 2056 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Lancets cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.In 2024, global Lancets production reached approximately 55.37 billion units, with an average global market price of around 30.22 US$ / k unit.

Market Drivers:

Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.

Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.

Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.

Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.

Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.

Market Challenges:

Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.

High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.

Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.

Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.

Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.

This report aims to provide a comprehensive presentation of the global market for Lancets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lancets by region & country, by Type, and by Application.

The Lancets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lancets.

Market Segmentation

By Company

• Roche
• Lifescan
• BD
• MTD Group
• Greiner Bio One
• Owen Mumford
• Cardinal Health
• Ascensia
• Abbott
• B. Braun
• Terumo
• I-SENS
• Nipro
• ICU Medical
• Sarstedt
• Sinocare
• Yueyue Medical
• Tianjin Huahong Medical
• Suzhou Shilai Medical
• Shandong Lianfa Medical
• Promisemed

Segment by Type

• Safety Lancets
• Ordinary Lancets

Segment by Application

• Blood Glucose Test
• Newborn Screening
• Rapid Blood Test
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Lancets in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Lancets Product Introduction
• 1.2 Global Lancets Market Size Forecast
  • 1.2.1 Global Lancets Sales Value (2020-2031)
  • 1.2.2 Global Lancets Sales Volume (2020-2031)
  • 1.2.3 Global Lancets Sales Price (2020-2031)
• 1.3 Lancets Market Trends & Drivers
  • 1.3.1 Lancets Industry Trends
  • 1.3.2 Lancets Market Drivers & Opportunity
  • 1.3.3 Lancets Market Challenges
  • 1.3.4 Lancets Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Lancets Players Revenue Ranking (2024)
• 2.2 Global Lancets Revenue by Company (2020-2025)
• 2.3 Global Lancets Players Sales Volume Ranking (2024)
• 2.4 Global Lancets Sales Volume by Company Players (2020-2025)
• 2.5 Global Lancets Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Lancets Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Lancets Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Lancets
• 2.9 Lancets Market Competitive Analysis
  • 2.9.1 Lancets Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Lancets Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Safety Lancets
  • 3.1.2 Ordinary Lancets
• 3.2 Global Lancets Sales Value by Type
  • 3.2.1 Global Lancets Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Lancets Sales Value, by Type (2020-2031)
  • 3.2.3 Global Lancets Sales Value, by Type (%) (2020-2031)
• 3.3 Global Lancets Sales Volume by Type
  • 3.3.1 Global Lancets Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Lancets Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Lancets Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Lancets Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Blood Glucose Test
  • 4.1.2 Newborn Screening
  • 4.1.3 Rapid Blood Test
  • 4.1.4 Other
• 4.2 Global Lancets Sales Value by Application
  • 4.2.1 Global Lancets Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Lancets Sales Value, by Application (2020-2031)
  • 4.2.3 Global Lancets Sales Value, by Application (%) (2020-2031)
• 4.3 Global Lancets Sales Volume by Application
  • 4.3.1 Global Lancets Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Lancets Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Lancets Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Lancets Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Lancets Sales Value by Region
  • 5.1.1 Global Lancets Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Lancets Sales Value by Region (2020-2025)
  • 5.1.3 Global Lancets Sales Value by Region (2026-2031)
  • 5.1.4 Global Lancets Sales Value by Region (%), (2020-2031)
• 5.2 Global Lancets Sales Volume by Region
  • 5.2.1 Global Lancets Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Lancets Sales Volume by Region (2020-2025)
  • 5.2.3 Global Lancets Sales Volume by Region (2026-2031)
  • 5.2.4 Global Lancets Sales Volume by Region (%), (2020-2031)
• 5.3 Global Lancets Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Lancets Sales Value, 2020-2031
  • 5.4.2 North America Lancets Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Lancets Sales Value, 2020-2031
  • 5.5.2 Europe Lancets Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Lancets Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Lancets Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Lancets Sales Value, 2020-2031
  • 5.7.2 South America Lancets Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Lancets Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Lancets Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Lancets Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Lancets Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Lancets Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Lancets Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Lancets Sales Value, 2020-2031
  • 6.3.2 United States Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Lancets Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Lancets Sales Value, 2020-2031
  • 6.4.2 Europe Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Lancets Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Lancets Sales Value, 2020-2031
  • 6.5.2 China Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Lancets Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Lancets Sales Value, 2020-2031
  • 6.6.2 Japan Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Lancets Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Lancets Sales Value, 2020-2031
  • 6.7.2 South Korea Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Lancets Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Lancets Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Lancets Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Lancets Sales Value, 2020-2031
  • 6.9.2 India Lancets Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Lancets Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Roche
  • 7.1.1 Roche Company Information
  • 7.1.2 Roche Introduction and Business Overview
  • 7.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Roche Lancets Product Offerings
  • 7.1.5 Roche Recent Development
• 7.2 Lifescan
  • 7.2.1 Lifescan Company Information
  • 7.2.2 Lifescan Introduction and Business Overview
  • 7.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Lifescan Lancets Product Offerings
  • 7.2.5 Lifescan Recent Development
• 7.3 BD
  • 7.3.1 BD Company Information
  • 7.3.2 BD Introduction and Business Overview
  • 7.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 BD Lancets Product Offerings
  • 7.3.5 BD Recent Development
• 7.4 MTD Group
  • 7.4.1 MTD Group Company Information
  • 7.4.2 MTD Group Introduction and Business Overview
  • 7.4.3 MTD Group Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 MTD Group Lancets Product Offerings
  • 7.4.5 MTD Group Recent Development
• 7.5 Greiner Bio One
  • 7.5.1 Greiner Bio One Company Information
  • 7.5.2 Greiner Bio One Introduction and Business Overview
  • 7.5.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Greiner Bio One Lancets Product Offerings
  • 7.5.5 Greiner Bio One Recent Development
• 7.6 Owen Mumford
  • 7.6.1 Owen Mumford Company Information
  • 7.6.2 Owen Mumford Introduction and Business Overview
  • 7.6.3 Owen Mumford Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Owen Mumford Lancets Product Offerings
  • 7.6.5 Owen Mumford Recent Development
• 7.7 Cardinal Health
  • 7.7.1 Cardinal Health Company Information
  • 7.7.2 Cardinal Health Introduction and Business Overview
  • 7.7.3 Cardinal Health Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Cardinal Health Lancets Product Offerings
  • 7.7.5 Cardinal Health Recent Development
• 7.8 Ascensia
  • 7.8.1 Ascensia Company Information
  • 7.8.2 Ascensia Introduction and Business Overview
  • 7.8.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Ascensia Lancets Product Offerings
  • 7.8.5 Ascensia Recent Development
• 7.9 Abbott
  • 7.9.1 Abbott Company Information
  • 7.9.2 Abbott Introduction and Business Overview
  • 7.9.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Abbott Lancets Product Offerings
  • 7.9.5 Abbott Recent Development
• 7.10 B. Braun
  • 7.10.1 B. Braun Company Information
  • 7.10.2 B. Braun Introduction and Business Overview
  • 7.10.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 B. Braun Lancets Product Offerings
  • 7.10.5 B. Braun Recent Development
• 7.11 Terumo
  • 7.11.1 Terumo Company Information
  • 7.11.2 Terumo Introduction and Business Overview
  • 7.11.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Terumo Lancets Product Offerings
  • 7.11.5 Terumo Recent Development
• 7.12 I-SENS
  • 7.12.1 I-SENS Company Information
  • 7.12.2 I-SENS Introduction and Business Overview
  • 7.12.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 I-SENS Lancets Product Offerings
  • 7.12.5 I-SENS Recent Development
• 7.13 Nipro
  • 7.13.1 Nipro Company Information
  • 7.13.2 Nipro Introduction and Business Overview
  • 7.13.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Nipro Lancets Product Offerings
  • 7.13.5 Nipro Recent Development
• 7.14 ICU Medical
  • 7.14.1 ICU Medical Company Information
  • 7.14.2 ICU Medical Introduction and Business Overview
  • 7.14.3 ICU Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 ICU Medical Lancets Product Offerings
  • 7.14.5 ICU Medical Recent Development
• 7.15 Sarstedt
  • 7.15.1 Sarstedt Company Information
  • 7.15.2 Sarstedt Introduction and Business Overview
  • 7.15.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Sarstedt Lancets Product Offerings
  • 7.15.5 Sarstedt Recent Development
• 7.16 Sinocare
  • 7.16.1 Sinocare Company Information
  • 7.16.2 Sinocare Introduction and Business Overview
  • 7.16.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Sinocare Lancets Product Offerings
  • 7.16.5 Sinocare Recent Development
• 7.17 Yueyue Medical
  • 7.17.1 Yueyue Medical Company Information
  • 7.17.2 Yueyue Medical Introduction and Business Overview
  • 7.17.3 Yueyue Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Yueyue Medical Lancets Product Offerings
  • 7.17.5 Yueyue Medical Recent Development
• 7.18 Tianjin Huahong Medical
  • 7.18.1 Tianjin Huahong Medical Company Information
  • 7.18.2 Tianjin Huahong Medical Introduction and Business Overview
  • 7.18.3 Tianjin Huahong Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Tianjin Huahong Medical Lancets Product Offerings
  • 7.18.5 Tianjin Huahong Medical Recent Development
• 7.19 Suzhou Shilai Medical
  • 7.19.1 Suzhou Shilai Medical Company Information
  • 7.19.2 Suzhou Shilai Medical Introduction and Business Overview
  • 7.19.3 Suzhou Shilai Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Suzhou Shilai Medical Lancets Product Offerings
  • 7.19.5 Suzhou Shilai Medical Recent Development
• 7.20 Shandong Lianfa Medical
  • 7.20.1 Shandong Lianfa Medical Company Information
  • 7.20.2 Shandong Lianfa Medical Introduction and Business Overview
  • 7.20.3 Shandong Lianfa Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Shandong Lianfa Medical Lancets Product Offerings
  • 7.20.5 Shandong Lianfa Medical Recent Development
• 7.21 Promisemed
  • 7.21.1 Promisemed Company Information
  • 7.21.2 Promisemed Introduction and Business Overview
  • 7.21.3 Promisemed Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 Promisemed Lancets Product Offerings
  • 7.21.5 Promisemed Recent Development

8 Industry Chain Analysis

• 8.1 Lancets Industrial Chain
• 8.2 Lancets Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Lancets Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Lancets Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer